ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Orthofix (OFIX) To Contact Him Directly To Discuss Their Options
If you are a long-term stockholder in Orthofix between October 11, 2022, and September 12, 2023 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX) on behalf of long-term stockholders following a class action complaint that was filed against Orthofix on August 21, 2024 with a Class Period from October 11, 2022, and September 12, 2023. Our investigation concerns whether the board of directors of Orthofix have breached their fiduciary duties to the company.
On October 11, 2022, Orthofix and SeaSpine, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that they entered into a definitive agreement to combine in an all-stock merger of equals (the “Merger”). According to the release and corresponding conference call with securities analysts, Defendant Keith Valentine (“Valentine”), SeaSpine’s President and Chief Executive Officer (“CEO”), would serve as President and CEO and be appointed to the Board of Directors (the “Board”) of the combined company.
On November 21, 2022, Orthofix and SeaSpine announced that, effective upon the completion of the merger, Defendant John Bostjancic (“Bostjancic”), SeaSpine’s Chief Financial Officer (“CFO”) and Chief Operating Officer, and Defendant Patrick Keran (“Keran”), SeaSpine’s Senior Vice President and General Counsel, would serve as CFO and Chief Legal Officer (“CLO”) of the combined company, respectively. On January 4, 2023, Orthofix and SeaSpine announced the successful completion of the Merger.
Throughout the Class Period, Defendants allegedly issued false and misleading statements and/or failed to disclose adverse facts about the Company’s management team. When the truth about the Company’s management team was revealed, the price of Orthofix common stock suffered sharp declines. As a result, Plaintiff and other Class members have suffered significant losses and damages.
If you are a long-term stockholder of Orthofix, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
